Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series

Autor(es):Mostrar menos -

Luis-Silva, Fabio ; Menegueti, Mayra Goncalves ; Sato, Lucas ; Peres, Leandro Moreira ; Sepeda, Corina dos Reis ; Petroski-Moraes, Bruno C. ; Donadel, Mariana Derminio ; Gallo, Gabriela Bortoleto ; Jordani, Maria Cecilia ; Mestriner, Fabiola ; Becari, Christiane ; Basile-Filho, Anibal ; Evora, Paulo R. B. ; Martins-Filho, Olindo Assis ; Auxiliadora-Martins, Maria

• Tipo de documento: Artigo Científico
• Fonte: MEDICINE; v. 102, n. 4, p. 7-pg., 2023-01-27.

Resumo

Rationale:Methylene blue (MB) has been used to increase blood pressure in septic shock, acting on the activity of guanylate cyclase and nitric oxide synthase. Patience concerns:The aim of this study is to demonstrate the benefit of MB in early phase of septic shock.Diagnoses: We report 6 cases of patients with septic shock with up to 72 hours of evolution. Interventions:We used MB after fluid replacement, use of norepinephrine and vasopressin. Patients received a loading dose of MB and maintenance for 48 hours. Outcomes:All patients presented a reduction in the dose of vasopressors and lactate levels soon after the administration of the loading dose of MB, an effect that was maintained with the maintenance dose for 48 hours. Interleukin 6 and interleukin 8 were elevated at the beginning of the septic condition, with a progressive and marked reduction after the beginning of MB infusion, demonstrating a role of MB in reducing the inflammatory activity. Lessons:This case series suggests that MB used early in the treatment of septic shock may be useful in reducing vasopressor dose and lactate levels. Further studies are still required to further validate these findings. (AU)

• Processo FAPESP: 18/26553-0 - Estudo prospectivo, randomizado, controlado por placebo sobre os efeitos hemodinâmicos e metabólicos do azul de metileno no choque séptico
• Beneficiário: Maria Auxiliadora Martins
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 17/21539-6 - Contribuição do sistema renina angiotensina na fisiopatologia do Aneurisma de Aorta Abdominal
• Beneficiário: Christiane Becari
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores
• Processo FAPESP: 18/23718-8 - Contribuição do sistema renina angiotensina na fisiopatologia do aneurisma de aorta abdominal
• Beneficiário: Christiane Becari
• Modalidade de apoio: Bolsas no Brasil - Jovens Pesquisadores
• Processo FAPESP: 21/01195-6 - Avaliação dos mediadores inflamatórios e óxido nítrico em plasma de pacientes sépticos submetidos ao tratamento com azul de metileno
• Beneficiário: Bruno Cesar Petroski Moraes
• Modalidade de apoio: Bolsas no Brasil - Programa Capacitação - Treinamento Técnico